Pharmafile Logo
Pharmafocus logo
Advanced Search
dialogo

DIA: Pharmacovigilance conference

May 15, 2018
Medical Communications, Research and Development dia

We are in the midst of a breath-taking series of changes in the world of pharmacovigilance, both within Europe and …

News
shutterstock_159488225

New cancer clinical trial model promises to cut costs and development time

May 15, 2018
Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, Cancer, MD AndersonCancer Center, clinical trials, pharma

Researchers from the University of Texas MD Anderson Cancer Center have been developing and testing a new model for the …

News
fda_building

FDA issues warning letter over potential for poisoning at India plant

May 15, 2018
Manufacturing and Production FDA, India, biotech, drugs, pharma, pharmaceutical

The FDA has noted a number of failings at a plant in Gujarat, India, but mostly significantly was the finding …

News
mosquito-49141_960_720

Smell test targets asymptomatic malaria carriers

May 15, 2018
Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical

Asymptomatic carriers of malaria may be responsible for the onwards transmission of up to 90% of cases, highlighting the importance …

News
flu_vaccine

Emergex secures funds in race to develop universal flu vaccine

May 15, 2018
Manufacturing and Production, Sales and Marketing Emergex, Innovate UK, biotech, drugs, influenza vaccine, pharma, pharmaceutical

UK-based biotech, Emergex Vaccines, has received £1 million to push its universal flu vaccine through preclinical tests, in the hope …

News
lilly_building_with_american_flag_web

Lilly chalks up another acquisition with AurKa for $575m

May 14, 2018
Manufacturing and Production, Sales and Marketing AurKa, Cancer, Eli Lilly, acquisition, oncology, pharma

Swiftly following up its $1.6 billion splash to pick up Armo BioSciences last week, Eli Lilly has agreed to acquire …

News

Bringing the PRO to fruition

May 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PROs, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …

Feature
shutterstock_273326141

Medigene and bluebird bio expand immunotherapy partnership to $1.5bn

May 14, 2018
Research and Development, Sales and Marketing Bluebird Bio, Cancer, Medigene, pharma

Medigene has announced that it has bolstered the existing partnership it has in place with US firm bluebird bio, originally …

News

Takeda financials show why the Shire deal was needed

May 14, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …

News
donald_j

Pharma unfazed by Trump price-reduction proposals

May 14, 2018
Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical

President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …

News
novartis_side_building

FDA awards first paediatric MS approval to Novartis’ Gilenya

May 14, 2018
Sales and Marketing FDA, gilenya, multiple sclerosis, pharma

The FDA has awarded approval for what it says is its first drug for the treatment of multiple sclerosis (MS) …

News
webinar

Free webinar: EU risk management for oncology medicines

May 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, dia

News
david_horn_solomon

Akari CEO resigns over allegations of spending company funds

May 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, appointment

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …

Appointment

Janssen’s Tremfya gets go-ahead from NICE in plaque psoriasis

May 11, 2018
Medical Communications, Sales and Marketing Janssen, NICE, Tremfya, UK, pharma, psoriasis

NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

May 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical

It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …

News
roche

Roche’s Tecentriq/Cotellic combo therapy fails to impress in colorectal cancer

May 11, 2018
Medical Communications, Research and Development Cancer, Cotellic, Roche, pharma, tecentriq

Roche has been rocked by a Phase 3 weak showing from its combination Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people …

News

AZ’s Fasenra stumbles in P3 for COPD

May 11, 2018
Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical

AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …

News
dialogo

DIA – CMC Workshop

May 11, 2018
Medical Communications dia

This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena. Attendees from …

News
andy_c4

C4 Therapeutics fills out C-Suite with CEO appointment

May 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical

C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …

Appointment
lilly2_web

Lilly moves quickly to secure $1.6bn buyout of Armo

May 10, 2018
Medical Communications, Sales and Marketing Armo Biosciences, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026